Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
eli lilly
7
×
genentech
7
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
indiana blog main
indiana top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
celgene
deals
johnson & johnson
bristol-myers squibb
glaxosmithkline
investing
ipo
novartis
What
bio
roundup
drug
fda
cancer
approval
blueprint
companies
drugs
known
latest
medicines
news
pharmaceutical
regulatory
ret
address
alzheimer’s
appetite
approved
approves
august
biopharma
biotech
black
bread
busy
butter
buyout
candidate
carries
cash
certain
congress
congressional
crispr
currently
days
decisions
designed
Language
unset
Current search:
genentech
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More